The ASX must be looking at this and thinking what the hell is going on, an obviously under valued company gets an FDA approval for a product and the price drops, I would think a please explain notice would be in order,cheers.
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx, page-26
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #